ENTITY

Glyconex Inc (4168 TT)

Health Care • Taiwan

GlycoNex Inc. owns complete R&D facilities including SPF animal room, cell culture room and glyco analysis equipment. The Company's main business is the development and authorization of monoclonal anti bodies and other services on carbohydrate antigen and protein drugs.

Refresh

No events found

We’ll display events we find for Glyconex Inc here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00